论文部分内容阅读
阿司匹林已是现今治疗急性心肌梗死、不稳定型和稳定型心绞痛、脑梗塞、某些心房纤颤等疾病不可缺少的药物,也是防止上述疾病患者再次发病的首选药物。放过支架、做过冠状动脉搭桥手术的患者也离不开阿司匹林的长期“呵护”。之所以这样做并已成为常规,是由于上述疾病患者服用阿司匹林后,其死亡率降低、缺血事件再发作减少、冠状动脉术后(手术或介入)血管事件减少等诸多好处,远远超过可能发生的出血风险。
Aspirin is currently the treatment of acute myocardial infarction, unstable and stable angina, cerebral infarction, certain atrial fibrillation and other diseases indispensable drugs, but also prevent the disease in patients with the disease again the drug of choice. Stents, coronary artery bypass graft surgery done patients also can not do without long-term “care ” of aspirin. The reason for this has become routine because of the reduced mortality, reduced reoccurrence of ischemic events, and reduced vascular events after surgery (surgery or intervention) in patients with these conditions, which far outweigh the potential benefits of aspirin Risk of bleeding.